Irritable Bowel Syndrome
Updated: 05/15/2006

References

Alaradi O, Barkin JS. Irritable bowel syndrome: Update on pathogenesis and management. Med Princ Pract. 2002 Jan;11(1):2–17.

Bodemar G, Ragnarsson G. [Irritable bowel syndrome. Survey of definitions, differential diagnosis and pathogenesis]. Lakartidningen. 2001 Feb 14;98(7):666–71.

Bundy R, Walker AF, et al. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: A subset analysis. J Altern Complement Med. 2004 Aug;10(4):667–9.

Camilleri M. Probiotics and irritable bowel syndrome: Rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006 Mar;40(3):264–9.

Chey WY, Jin HO, et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001 May;96(5):1499–506.

Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med. 2004 Oct;95(5):427–41.

De Schryver AM, Samsom M. New developments in the treatment of irritable bowel syndrome. Scand J Gastroenterol Suppl. 2000;(232):38–42.

Delvaux M. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome. Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):747–71.

Floch MH, Narayan R. Diet in the irritable bowel syndrome. J Clin Gastroenterol. 2002 Jul;35(1 Suppl):S45–S52.

Hale LP. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int Immunopharmacol. 2004 Feb;4(2):255–64.

Hasler WL. Augmented visceral perception. Curr Treat Options Gastroenterol. 2001 Aug;4(4):339–49.

Jalihal A, Kurian G. Ispaghula therapy in irritable bowel syndrome: Improvement in overall well-being is related to reduction in bowel dissatisfaction. J Gastroenterol Hepatol. 1990 Sep;5(5):507–13.

Kajander K, Hatakka K, et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Aliment Pharmacol Ther. 2005 Sep 1;22(5):387–94.

Kasper DL, Braunwald E, et al. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:2298–303.

Kim HJ, Vazquez Roque MI, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005 Oct;17(5):687–96.

Kline RM, Kline JJ, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001 Jan;138(1):125–8.

Kumar A, Kumar N, et al. Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: Correlation of symptom relief with whole gut transit time and stool weight. Gut. 1987 Feb;28(2):150–5.

Langmead L, Rampton DS. Review article: Herbal treatment in gastrointestinal and liver disease—benefits and dangers. Aliment Pharmacol Ther. 2001 Sep;15(9):1239–52.

Lindor KD, Sheeler RD. Irritable Bowel Syndrome. Available at: http://www.familypractice.com/references/referencesframe.htm?main=/references/ABFPGuides/Bowel/bowel.htm. Accessed April 20, 2005.

Logan AC, Beaulne TM. The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: A case report. Altern Med Rev. 2002 Oct;7(5):410–7.

Moyle R, Fairbairn DJ, et al. Developing pineapple fruit has a small transcriptome dominated by metallothionein. J Exp Bot. 2005 Jan;56(409):101–12.

NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases). Irritable Bowel Syndrome. NIH Publication No. 06–693

February 2006. Available at: http://digestive.niddk.nih.gov/ddiseases/pubs/ibs/. Accessed May 12, 2006.

Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: A critical review and metaanalysis. Am J Gastroenterol. 1998 Jul;93(7):1131–5.

Quilt P, Crockett D. Fructooligosaccharides and Other Prebiotics—FOS. 2003 Jun. Available at: http://www.findarticles.com/p/articles/mi_m0ISW/is_2003_June/ai_102372155. Accessed April 21, 2005.

Roth E, Spittler A, et al. [Glutamine: Effects on the immune system, protein balance and intestinal functions]. Wien Klin Wochenschr. 1996;108(21):669–76.

Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S104–S106.

Saller R, Iten F, et al. [Dyspeptic pain and phytotherapy—a review of traditional and modern herbal drugs]. Forsch Komplementarmed Klass Naturheilkd. 2001 Oct;8(5):263–73.

Schneeman BO. Gastrointestinal physiology and functions. Br J Nutr. 2002 Nov;88 Suppl 2:S159–63.

Sghir A, Chow JM, et al. Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. J Appl Microbiol. 1998 Oct;85(4):769–77.

Spiller R. Pharmacotherapy: Non-serotonergic mechanisms. Gut. 2002 Jul;51 Suppl 1:i87–i90.

Talley NJ, Spiller R. Irritable bowel syndrome: A little understood organic bowel disease? Lancet. 2002 Aug 17;360(9332):555–64.

Terada T, Kitamura Y, et al. Normal and abnormal development of the human intrahepatic biliary system: A review. Tohoku J Exp Med. 1997 Jan;181(1):19–32.

Tomas-Ridocci M, Anon R, et al. [The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo]. Rev Esp Enferm Dig. 1992 Jul;82(1):17–22.

van der Hulst RR, von Meyenfeldt MF, et al. Glutamine: An essential amino acid for the gut. Nutrition. 1996 Nov;12(11–12 Suppl):S78–S81.

Whitehead WE, Palsson O, et al. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology. 2002 Apr;122(4):1140–56.

Ziegler TR, Bazargan N, et al. Glutamine and the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2000 Sep;3(5):355–62.